arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

TScan Therapeutics, Inc.

TCRX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.22
▼ -3.6% Today
as of Oct 22, 16:52 ET
Last 30 days -29.41% Sep 14 → Oct 22
$0.20 $0.24 $0.29 $0.33 $0.38 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.22
High
$0.22
Low
$0.21
Volume
$299,115
Avg Vol
$758,027
Mkt Cap
$20M
P/E (TTM)
—
Beta
—
52w High
$2.43
52w Low
$0.20
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 2 items

TCRX earnings at a glance

Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±6.3% on average; after the most recent report on May 6, 2026 it moved +3.3%. TCRX beat the consensus EPS estimate in 2 of its last 4 reported quarters. The share price of $0.22 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.20
$2.43
1% of range
Avg surprise (last 4)
+6.8%
Avg reaction (last 2)
-3.0%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.93$-0.75$-0.57$-0.40$-0.22 Actual $-0.93Actual $-0.51Actual $-0.24Actual $-0.32Actual $-0.28Actual $-0.25Actual $-0.26Est $-0.28Actual $-0.28Est $-0.28Actual $-0.28Est $-0.35Actual $-0.22Est $-0.22Actual $-0.23 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-37M$-27M$-17M$-7M$3M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.23 — — — — financials
Wed May 6, 2026Mar/2026 $-0.22 $-0.22 0.0% +15.4% +3.3% earnings
Wed Nov 12, 2025Sep/2025 $-0.28 $-0.35 +20.0% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.28 $-0.28 0.0% — — earnings
Tue May 6, 2025Mar/2025 $-0.26 $-0.28 +7.1% — -9.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.25 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.28 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.32 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.24 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.51 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.93 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1M$982,000—$3M$3M$2M—$1M
Cost of revenue————————
Gross profit————————
Operating income$-30M$-29M—$-37M$-39M$-36M—$-33M
Net income$-30M$-29M—$-36M$-37M$-34M—$-30M
EPS (diluted)$-0.23$-0.22—$-0.28$-0.28$-0.26—$-0.25

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$100M$128M$152M$170M$169M$154M$179M$133M
Inventory————————
Total current assets$104M$133M$157M$188M$221M$255M$293M$274M
Total assets$171M$202M$229M$262M$299M$333M$371M$348M
Long-term debt$21M$33M$33M$32M$32M$32M$32M$31M
Total liabilities$102M$105M$106M$118M$122M$123M$130M$119M
Total equity$69M$97M$123M$144M$177M$210M$241M$229M

Implied volatility — last 90 days

No IV snapshots yet for TCRX.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

TCRX earnings FAQ

How does TCRX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±6.3%, up 1 times and down 1 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.